Symptomatic Genetic Dilated Cardiomyopathy Clinical Trials in Washington D.C., District of Columbia

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy